APA (7th ed.) Citation

X, S., J, Z., X, G., S, L., F, Z., & Y, S. (2026). A novel lipid droplet-related prognostic signature reveals CIDEC as a key biomarker for pancreatic adenocarcinoma. Frontiers in oncology, 16, 1845259. https://doi.org/10.3389/fonc.2026.1845259

Chicago Style (17th ed.) Citation

X, Shao, Zhu J, Gao X, Li S, Zhong F, and Shi Y. "A Novel Lipid Droplet-related Prognostic Signature Reveals CIDEC as a Key Biomarker for Pancreatic Adenocarcinoma." Frontiers in Oncology 16 (2026): 1845259. https://doi.org/10.3389/fonc.2026.1845259.

MLA (9th ed.) Citation

X, Shao, et al. "A Novel Lipid Droplet-related Prognostic Signature Reveals CIDEC as a Key Biomarker for Pancreatic Adenocarcinoma." Frontiers in Oncology, vol. 16, 2026, p. 1845259, https://doi.org/10.3389/fonc.2026.1845259.